Skip to main content
. Author manuscript; available in PMC: 2024 Aug 16.
Published in final edited form as: J Rheumatol. 2009 Feb 27;36(11):2470–2475. doi: 10.3899/jrheum.080586

Table 1.

Participant characteristics. Values are number (%) unless otherwise indicated.

Characteristic Patients, n = 198 Controls, n = 299 p
Age yrs, mean ± SD [range] 39 ± 14 [15–76] 41 ± 14 [16–75] 0.087
0.9312
Male 19 (9.6) 28 (9.4)
Female 179 (90.4) 271 (90.6)
< 0.0001
African-American and other minorities 126 (63.6) 97 (32.4)
White 72 (36.4) 202 (67.6)
College graduate 0.009
  Yes 47 (23.7) 104 (34.8)
  No 151 (76.3) 195 (65.2)
Education 0.003
  Did not complete high school 36 (18.2) 26 (8.7)
  Completed high school 49 (24.8) 63 (21.0)
  Some college 66 (33.3) 106 (35.5)
  Completed college 47 (23.7) 104 (34.8)
Clinical features
  Arthritis 143 (73.7)
  Pleuritis 76 (39.6)
  Pericarditis 26 (13.5)
  Seizures/Psychosis 12 (6.2)
  Thrombocytopenia 22 (11.4)
  Lupus nephritis 47 (24.2)
  Anti-dsDNA antibodies 50 (26.7)

Number of missing data: 5 for arthritis, 7 for pleuritis, 6 for pericarditis, 6 for seizures/psychosis, 6 for thrombocytopenia, 5 for lupus nephritis, and 12 for anti-dsDNA antibodies. Reasons for missing data were lack of permission for use of medical record data for the clinical failures data and non-participation in the blood sample collection for the anti-dsDNA antibody data.